Related Experiment Video
Updated: Aug 18, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
The effect of letrozole on bone age progression, predicted adult height, and adrenal gland function
Alexander Karmazin1, Wayne V Moore, Jadranka Popovic
1Section of Endocrinology, Department of Pediatrics, Children's Mercy Hospitals, Kansas City, MO 64108, USA.
Abstract:
A common problem in pediatric endocrinology is limited growth potential resulting from advancing skeletal maturation. We determined the efficacy of letrozole, an aromatase inhibitor, on delaying bone age advancement in adolescent males with limited growth potential. Twenty-four patients met the study inclusion criteria. Six patients treated with androgen were analyzed separately. Low-dose ACTH stimulation tests were performed to ascertain the effect of letrozole on adrenal gland function. In patients not on androgen, bone age progression decelerated from 1.51+/-0.57 (deltabone age/deltachronological age) before treatment to 0.68+/-0.66 on therapy (mean duration 12.4 months; p <0.0005). Predicted adult height standard deviation scores (SDS) increased from -1.41+/-0.54 to -0.64+/-0.65 on treatment (p <0.0005). Similar results were noted in androgen-treated patients. Approximately one-fourth of patients displayed subnormal responsiveness to ACTH. In summary: 1) letrozole decelerates skeletal maturation, resulting in significant increases in predicted adult height, and 2) letrozole causes mild adrenal suppression.
Insights
Letrozole, an aromatase inhibitor, effectively delays bone age advancement in adolescent males, significantly increasing predicted adult height. However, it may cause mild adrenal suppression.
Area of Science:
- Pediatric Endocrinology
- Bone Metabolism
- Pharmacology
Background:
- Advancing skeletal maturation limits growth potential in pediatric endocrinology.
- Aromatase inhibitors are explored for managing growth disorders.
Purpose of the Study:
- To determine the efficacy of letrozole in delaying bone age advancement in adolescent males with limited growth potential.
- To assess the impact of letrozole on predicted adult height and adrenal function.
Main Methods:
- A study involving 24 adolescent males with limited growth potential.
- Treatment with letrozole, with a subgroup also receiving androgen therapy.
- Low-dose ACTH stimulation tests to evaluate adrenal gland function.
Main Results:
- Letrozole significantly decelerated bone age progression (p <0.0005).
- Predicted adult height standard deviation scores (SDS) increased significantly (p <0.0005).
- Mild adrenal suppression was observed in approximately one-fourth of patients.
Conclusions:
- Letrozole is effective in decelerating skeletal maturation, leading to improved predicted adult height in adolescent males.
- Letrozole treatment is associated with mild adrenal suppression.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Menopause
Nature and Nurture
The Effect of Aging on Tissues
Bone Remodeling
